Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

SMG 1190.1

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS

FOOD AND DRUG ADMINISTRATION

OFFICE OF GLOBAL REGULATORY OPERATIONS AND POLICY

Effective Date: 07/08/2011

[PDF Version]

1. OFFICE OF GLOBAL REGULATORY OPERATIONS AND POLICY (DLL).

A. Provides executive oversight, strategic leadership, and policy direction to FDA’s domestic and international product quality and safety efforts, including global collaboration, global data-sharing, development and harmonization of standards, field operations, compliance, and enforcement activities

B. Drives improvement in FDA’s risk analytics and IT capability, in conjunction with the Office of Information Management, to enhance FDA’s gathering and use of intelligence in directing its regulatory efforts

C. Leverages public and private sector third parties to increase FDA’s global knowledge and coverage

D. Convenes and chairs a Global Programs Board, consisting of the Associate Commissioner for Regulatory Affairs, the Directors of all FDA Product Centers, and other agency leaders, in order to coordinate and enhance FDA’s global efforts

E. Provides executive leadership and management to all programs in the Office of Regulatory Affairs and the Office of International Programs

F. Exercises, on behalf of the Commissioner, direct line authority over the Office of Regulatory Affairs and the Office of International Programs

G. Exercises, on behalf of the Commissioner, all international and Office of Regulatory Affairs-related legal authorities that the Commissioner is empowered to exercise under the Federal Food, Drug, and Cosmetic Act, as amended, the Public Health Service Act, and other applicable laws

H. Represents FDA on matters relating to domestic and international product quality and safety efforts in dealings with the executive branch, Congress, foreign governments and international organizations, and others

2. AUTHORITY AND EFFECTIVE DATE.

The functional statements for this Office were approved by the Secretary of Health and Human Services effective, July 8, 2011.

STATUS (I, R, C)DATE APPROVEDLOCATION OF CHANGE HISTORYCONTACTAPPROVING OFFICIAL
Initial07/08/2011N/aOO/OMSecretary of Health and Human Services
-
-
-
-